Seoul, Korea — November 2025
At BIOPLUS-INTERPHEX Korea 2025 (BIX 2025), Dongou MF showcased its advanced polymer-based microfiltration and solid–liquid separation systems, engineered to meet the demanding requirements of pharmaceutical and biopharmaceutical production environments.
With over 40 years of expertise in industrial filtration technology, Dongou develops high-performance solutions that help pharmaceutical producers and API manufacturers enhance product purity, streamline process efficiency, and maintain strict GMP compliance throughout production.
To address the critical purification and recovery stages of pharmaceutical manufacturing, Dongou’s integrated filtration systems offer proven reliability across multiple process steps:
·Activated Carbon Filtration–Dewatering Systems — Integrated purification and drying for enhanced efficiency.
·Pd/C Catalyst Recovery & Filtration — Maximize reuse cycles and reduce material costs.
·Pre-Crystallization Liquor Filtration — Ensure crystal purity and yield.
·Fermentation Broth Clarification & Polishing — Achieve superior product quality with robust filtration.
Built for Precision, Safety & Sustainability
·Closed-system design – Prevents contamination and ensures GMP compliance.
·Smart PLC automation – Fully automated control for consistent, hands-free operation.
·High recovery rates – >95% catalyst and active ingredient recovery.
·Corrosion-resistant lining – Compatible with various pharmaceutical media.
·Sustainable efficiency – Continuous filtration, reduced energy use, and minimal waste.
Today, Dongou’s solutions are trusted by leading pharmaceutical and bioprocessing enterprises worldwide, helping them achieve cleaner, safer, and more sustainable production.
From laboratory-scale validation to full-scale GMP facilities, Dongou continues to support its partners with reliable, precision-engineered filtration systems built for long-term performance.
